ZHEJIANG GONGDONG MEDICAL TECHNOLOGY CO., LTD. Financials Zhejiang Gongdong Medical Technology Co., Ltd.
Equities
605369
CNE1000042X4
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 47.45 CNY | +3.08% |
|
+10.02% | -14.99% |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 4,620 | 16,136 | 11,895 | 6,286 | 5,344 | - |
| Enterprise Value (EV) 1 | 4,620 | 16,136 | 11,895 | 6,286 | 5,344 | 5,344 |
| P/E ratio | 11.9 x | 51.7 x | 36.3 x | 57.5 x | 17.3 x | 13.3 x |
| Yield | - | 0.96% | 0.28% | 0.54% | 3.75% | 5.06% |
| Capitalization / Revenue | - | 13.5 x | 8.1 x | 6.45 x | 3.51 x | 2.69 x |
| EV / Revenue | - | 13.5 x | 8.1 x | 6.45 x | 3.51 x | 2.69 x |
| EV / EBITDA | - | 42.3 x | 28.8 x | 32 x | 13 x | 9.85 x |
| EV / FCF | - | - | 107,528,297 x | - | - | - |
| FCF Yield | - | - | 0% | - | - | - |
| Price to Book | - | 11.6 x | 7.47 x | 3.84 x | 2.99 x | - |
| Nbr of stocks (in thousands) | 112,000 | 112,608 | 112,627 | 112,615 | 112,615 | - |
| Reference price 2 | 41.25 | 143.3 | 105.6 | 55.82 | 47.45 | 47.45 |
| Announcement Date | 3/7/21 | 4/17/22 | 4/24/23 | 4/26/24 | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | 1,194 | 1,469 | 975.1 | 1,524 | 1,984 |
| EBITDA 1 | - | 381.2 | 412.5 | 196.2 | 412.5 | 542.5 |
| EBIT 1 | - | 359.7 | 371.8 | 119.7 | 356 | 466 |
| Operating Margin | - | 30.12% | 25.32% | 12.28% | 23.35% | 23.49% |
| Earnings before Tax (EBT) 1 | - | 360.7 | 370.7 | 119.2 | 356.5 | 467 |
| Net income 1 | 225.9 | 311 | 326 | 109.1 | 308 | 403 |
| Net margin | - | 26.04% | 22.2% | 11.19% | 20.2% | 20.31% |
| EPS 2 | 3.480 | 2.770 | 2.910 | 0.9700 | 2.735 | 3.580 |
| Free Cash Flow | - | - | 110.6 | - | - | - |
| FCF margin | - | - | 7.53% | - | - | - |
| FCF Conversion (EBITDA) | - | - | 26.82% | - | - | - |
| FCF Conversion (Net income) | - | - | 33.93% | - | - | - |
| Dividend per Share 2 | - | 1.380 | 0.3000 | 0.3000 | 1.780 | 2.400 |
| Announcement Date | 3/7/21 | 4/17/22 | 4/24/23 | 4/26/24 | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow | - | - | 111 | - | - | - |
| ROE (net income / shareholders' equity) | - | 24% | 22.1% | 6.71% | 16.7% | 19.5% |
| ROA (Net income/ Total Assets) | - | 20.3% | 18.3% | 5.83% | 14.1% | 16.2% |
| Assets 1 | - | 1,533 | 1,779 | 1,873 | 2,192 | 2,488 |
| Book Value Per Share 2 | - | 12.30 | 14.10 | 14.50 | 15.90 | - |
| Cash Flow per Share 2 | - | 3.320 | 2.510 | 1.650 | 3.460 | 4.560 |
| Capex 1 | - | 276 | 172 | 122 | 216 | 219 |
| Capex / Sales | - | 23.07% | 11.72% | 12.49% | 14.17% | 11.01% |
| Announcement Date | 3/7/21 | 4/17/22 | 4/24/23 | 4/26/24 | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
47.45
CNY
Average target price
70
CNY
Spread / Average Target
+47.52%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -14.99% | 737M | |
| +11.84% | 27.79B | |
| -32.98% | 2.98B | |
| -15.97% | 2.52B | |
| +11.90% | 2.34B | |
| -1.11% | 1.91B | |
| -13.37% | 1.83B | |
| -7.78% | 1.39B | |
| -0.38% | 1.27B | |
| +4.01% | 1.13B |
- Stock Market
- Equities
- 605369 Stock
- Financials Zhejiang Gongdong Medical Technology Co., Ltd.
